Use of enoxacin in a patient with cystic fibrosis.
Miller
M G
MG
Ghoneim
A T
AT
Littlewood
J M
JM
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D015365:Enoxacin; D006801:Humans; D008297:Male; D009287:Naphthyridines / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*
D000890:Anti-Infective Agents; D009287:Naphthyridines; D015365:Enoxacin